Burke TW - Search Results

1

Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer.

Frumovitz M, Bodurka DC, Broaddus RR, Coleman RL, Sood AK, Gershenson DM, Burke TW, Levenback CF. Frumovitz M, et al. Among authors: burke tw. Gynecol Oncol. 2007 Jan;104(1):100-3. doi: 10.1016/j.ygyno.2006.07.033. Epub 2006 Sep 11. Gynecol Oncol. 2007. PMID: 16963111 Clinical Trial.

2

Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy.

Levenback C, Coleman RL, Burke TW, Lin WM, Erdman W, Deavers M, Delpassand ES. Levenback C, et al. Among authors: burke tw. J Clin Oncol. 2002 Feb 1;20(3):688-93. doi: 10.1200/JCO.2002.20.3.688. J Clin Oncol. 2002. PMID: 11821449

3

Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy.

Gordinier ME, Malpica A, Burke TW, Bodurka DC, Wolf JK, Jhingran A, Ramirez PT, Levenback C. Gordinier ME, et al. Among authors: burke tw. Gynecol Oncol. 2003 Sep;90(3):625-8. doi: 10.1016/s0090-8258(03)00374-3. Gynecol Oncol. 2003. PMID: 13678736

4

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

Slomovitz BM, Burke TW, Eifel PJ, Ramondetta LM, Silva EG, Jhingran A, Oh JC, Atkinson EN, Broaddus RR, Gershenson DM, Lu KH. Slomovitz BM, et al. Among authors: burke tw. Gynecol Oncol. 2003 Dec;91(3):463-9. doi: 10.1016/j.ygyno.2003.08.018. Gynecol Oncol. 2003. PMID: 14675663 Review.

5

Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer.

Frumovitz M, Ramirez PT, Tortolero-Luna G, Malpica A, Eifel P, Burke TW, Levenback C. Frumovitz M, et al. Among authors: burke tw. Gynecol Oncol. 2004 Jan;92(1):205-10. doi: 10.1016/j.ygyno.2003.09.022. Gynecol Oncol. 2004. PMID: 14751159

6

Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.

Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH. Slomovitz BM, et al. Among authors: burke tw. Gynecol Oncol. 2004 Oct;95(1):32-6. doi: 10.1016/j.ygyno.2004.06.052. Gynecol Oncol. 2004. PMID: 15385107

7

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.

Coleman RL, Broaddus RR, Bodurka DC, Wolf JK, Burke TW, Kavanagh JJ, Levenback CF, Gershenson DM. Coleman RL, et al. Among authors: burke tw. Gynecol Oncol. 2006 Apr;101(1):126-31. doi: 10.1016/j.ygyno.2005.09.041. Epub 2005 Nov 3. Gynecol Oncol. 2006. PMID: 16271384 Clinical Trial.

8

Sarcomatoid carcinoma of the cervix.

Brown J, Broaddus R, Koeller M, Burke TW, Gershenson DM, Bodurka DC. Brown J, et al. Among authors: burke tw. Gynecol Oncol. 2003 Jul;90(1):23-8. doi: 10.1016/s0090-8258(03)00200-2. Gynecol Oncol. 2003. PMID: 12821337

9

Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva.

Burke TW, Stringer CA, Gershenson DM, Edwards CL, Morris M, Wharton JT. Burke TW, et al. Gynecol Oncol. 1990 Sep;38(3):328-32. doi: 10.1016/0090-8258(90)90067-u. Gynecol Oncol. 1990. PMID: 2227543

10

Potential applications of intraoperative lymphatic mapping in vulvar cancer.

Levenback C, Burke TW, Morris M, Malpica A, Lucas KR, Gershenson DM. Levenback C, et al. Among authors: burke tw. Gynecol Oncol. 1995 Nov;59(2):216-20. doi: 10.1006/gyno.1995.0011. Gynecol Oncol. 1995. PMID: 7590476

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters